: Sepsis is a host's deleterious response to infection, which could lead to life-threatening organ dysfunction. Sepsis-associated acute kidney injury (SA-AKI) is the most frequent organ dysfunction and is associated with increased morbidity and mortality. Sepsis contributes to approximately 50% of all AKI in critically ill adult patients. A growing body of evidence has unveiled key aspects of the clinical risk factors, pathobiology, response to treatment, and elements of renal recovery that have advanced our ability to detect, prevent, and treat SA-AKI. Despite these advancements, SA-AKI remains a critical clinical condition and a major health burden, and further studies are needed to diminish the short and long-term consequences of SA-AKI. We review the current treatment standards and discuss novel developments in the pathophysiology, diagnosis, outcome prediction, and management of SA-AKI.
Sepsis-associated acute kidney injury - treatment standard / Zarbock, Alexander; Koyner, Jay L; Gomez, Hernando; Pickkers, Peter; Forni, Lui; Mitra K Nadim, Samira Bell, Michael Joannidis, Kianoush Kashani, Neesh Pannu, Melanie Meersch, Thiago Reis, Thomas Rimmelé, Sean M Bagshaw, Rinaldo Bellomo, Vicenzo Cantaluppi, Akash Deep, Silvia De Rosa, Xose Fernandez-Perez, Faeq Husain-Syed, Sandra L Kane-Gill, Yvelynne Kelly, Ravindra L Mehta, Patrick T Murray, Marlies Ostermann, John Prowle, Zaccaria Ricci, Emily J See, Antoine Schneider, Danielle E Soranno, Ashita Tolwani, Gianluca Villa, Claudio Ronco. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - ELETTRONICO. - (2023), pp. 1-10. [10.1093/ndt/gfad142]
Sepsis-associated acute kidney injury - treatment standard
Thiago Reis;Silvia De Rosa;Faeq Husain-Syed;Zaccaria Ricci;Gianluca Villa;
2023
Abstract
: Sepsis is a host's deleterious response to infection, which could lead to life-threatening organ dysfunction. Sepsis-associated acute kidney injury (SA-AKI) is the most frequent organ dysfunction and is associated with increased morbidity and mortality. Sepsis contributes to approximately 50% of all AKI in critically ill adult patients. A growing body of evidence has unveiled key aspects of the clinical risk factors, pathobiology, response to treatment, and elements of renal recovery that have advanced our ability to detect, prevent, and treat SA-AKI. Despite these advancements, SA-AKI remains a critical clinical condition and a major health burden, and further studies are needed to diminish the short and long-term consequences of SA-AKI. We review the current treatment standards and discuss novel developments in the pathophysiology, diagnosis, outcome prediction, and management of SA-AKI.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
